AZN: TEZSPIRE Reduces Nasal Polyp Severity And Surgery Need In CRSwNP Patients In Phase III Trial
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – The Phase III WAYPOINT trial results revealed that AstraZeneca (AZN.L, AZN) and Amgen’s (AMGN) TEZSPIRE (tezepelumab-ekko) significantly decreased nasal polyp severity, reduced the necessity for subsequent surgeries, and minimized systemic corticosteroid use in patien
:max_bytes(150000):strip_icc():format(jpeg)/10-habits-successful-people_round1-866293a21531421d8af8d8e93a54e1d5.png "10 Habits of Successful People and How You Can Boost Your Bottom Line")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2171984096-8f0c21e181f74ca3a4ffd7e55b740841.jpg "10 Crypto Influencers To Consider Following on Social Media")
:max_bytes(150000):strip_icc():format(jpeg)/INV-SPOTLIGHT-LIFEINSURANCE-01-LEAD-5-Top-Benefits-of-Life-Insurance-For-Families-1-FINAL-1-6f6a12ec2e984edabe35e404ef5a29be.png "Guide To Life Insurance: Top 5 Benefits for Families")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2172536461-a6611df0c6d24ed88b9df84ff8c8843f.jpg "How Does Your Net Worth Stack Up Against the Average for Your Income Level?")
:max_bytes(150000):strip_icc():format(jpeg)/INV-SPOTLIGHT-LIFEINSURANCE-06-RECIRC-How-Much-Life-Insurance-Coverage-Does-Your-Family-Need-1-FINAL-1-d6a43f78f54440a88ae5935491c9539e.png "How Much Life Insurance Coverage Does Your Family Need?")